These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 617902)

  • 21. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute.
    Guru KA; Kim HL; Piacente PM; Mohler JL
    Urology; 2007 Mar; 69(3):469-74. PubMed ID: 17382147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical cystectomy for residual of recurrent tumour after definitive radiotherapy (salvage cystectomy).
    Rasmussen RB; Knudsen JB; Sørensen BL; Walbom-Jørgensen S
    Dan Med Bull; 1988 Feb; 35(1):98-100. PubMed ID: 3342650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative irradiation and cystectomy for bladder cancer.
    Smith JA; Batata M; Grabstald H; Sogani PC; Herr H; Whitmore WF
    Cancer; 1982 Mar; 49(5):869-73. PubMed ID: 6800628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
    Mills RD; Fleischmann A; Studer UE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.
    Quek ML; Sanderson KM; Daneshmand S; Stein JP
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1007-16. PubMed ID: 15606329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Imaging procedures in preoperative lymph node staging of invasive bladder cancer. Necessary or superfluous?].
    Gottfried HW; Miller K; Brandes H; Henze E; Waidelich HA
    Urologe A; 1993 Jan; 32(1):56-8. PubMed ID: 8447046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
    Stein JP; Penson DF; Cai J; Miranda G; Skinner EC; Dunn MA; Groshen S; Lieskovsky G; Skinner DG
    J Urol; 2007 Mar; 177(3):876-81; discussion 881-2. PubMed ID: 17296365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 31. Bladder cancer in geriatric patients. Alternatives to radical cystectomy.
    Nitti VW; Macchia RJ
    Clin Geriatr Med; 1990 Feb; 6(1):173-84. PubMed ID: 2405977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
    Stein JP; Skinner DG
    BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of lymphatic metastasis in bladder cancer].
    Martínez-Piñeiro L; Madrid J; Julve E; García Cardoso JV; Ortega L; de la Peña J; Martínez-Piñeiro JA
    Arch Esp Urol; 1997 May; 50(4):365-71. PubMed ID: 9313045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal timing of radical cystectomy for patients with T1 bladder cancer.
    Bochner BH
    Urol Oncol; 2009; 27(3):329-31. PubMed ID: 19414124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of ratio based lymph node staging for bladder cancer.
    Herr HW
    J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
    Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
    Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
    Thompson IM
    J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100
    [No Abstract]   [Full Text] [Related]  

  • 40. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.